Niu D

ORCID: 0009-0007-4166-147X · 4 papers in corpus
2026
Discover oncology ·doi:10.1007/s12672-026-05058-1

Ovarian cancer (OC) remains a malignancy characterized by obscure risk factors and unfavorable prognosis. While 3-tert-butyl-4-hydroxyanisole (3-BHA) is suspected of exerting toxic effects on ovarian health, the precise molecular mechanisms…

2026
Frontiers in pharmacology ·doi:10.3389/fphar.2026.1878277

Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the most prevalent chronic liver disease worldwide, yet no pharmacological therapy has achieved regulatory approval. Flavonoids, plant-derived polyphenols encompass…

review 2025
·doi:10.22541/au.175454836.63818337/v1

Background Pain associated with endometriosis arises from the combined effects of inflammatory responses, tissue damage, and neural sensitization induced by ectopic endometrial lesions. Currently, oral non-peptide gonadotropin-releasing hor…

2021
Frontiers in cell and developmental biology ·doi:10.3389/fcell.2021.708980

Hexestrol (HES) is a synthetic non-steroidal estrogen that was widely used illegally to boost the growth rate in livestock production and aquaculture. HES can also be transferred to humans from treated animals and the environment. HES has b…